Remove Companies Remove Liabilities Remove Shareholders
article thumbnail

The $625 Billion Blunder I Believe Tesla Shareholders Are Making

The Motley Fool

Over the past 10 years, electric-vehicle (EV) maker Tesla (NASDAQ: TSLA) has been one of the top-performing companies within the broad-based S&P 500. Additionally, it's become one of the largest publicly traded companies. Beyond FSD, Musk and his company often have a hard time sticking to initially touted timelines.

article thumbnail

Google Parent Company Alphabet Just Proved Why Dividends Matter, Even for Growth Stocks

The Motley Fool

Just one quarter after Meta Platforms announced its first-ever dividend payout, Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) joined Meta, Microsoft , and Apple to become the fourth "Magnificent Seven" company to reward shareholders with a quarterly dividend. based company : $20.7 Alphabet's dividend will start at just $0.20

Companies 245
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Rocket Companies (RKT) Q3 2024 Earnings Call Transcript

The Motley Fool

Rocket Companies (NYSE: RKT) Q3 2024 Earnings Call Nov 12, 2024 , 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Thank you for standing by, and welcome to the Rocket Companies third quarter 2024 earnings conference call. Image source: The Motley Fool. You may begin.

Companies 241
article thumbnail

Will Viking Therapeutics Get Acquired?

The Motley Fool

Shares of the company have risen by 285% thus far, and that's even factoring in a recent pullback in price. Investors have become excited about the company's long-term prospects, as it has a promising weight-loss drug in its portfolio. And beyond just sheer valuation, a buyer will also want to consider the company's balance sheet.

article thumbnail

What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?

The Motley Fool

Now that it has an approved treatment in Casgevy, there's undoubtedly going to be more of a spotlight on the company. Here's why CRISPR could be an attractive acquisition target, and what it would mean for investors if the company is bought out this year. The company will share in the profits on Casgevy with Vertex.

Investors 246
article thumbnail

Why Spirit Airlines Stock Fell (Again) This Week

The Motley Fool

But the companies' proposed merger got shot down on anticompetitive grounds. This week, JetBlue officially announced it would not pursue any appeal to consummate the Spirit merger, leaving Spirit shareholders and management on their own. The company may be heading for bankruptcy shortly, which would wipe out 100% of the equity value.

article thumbnail

Why Rumble Stock Is Plummeting This Week

The Motley Fool

The company's share price was down 23% from last week's market close heading into this Friday's daily trading session, according to data from S&P Global Market Intelligence. 19, opening the door for insiders at the company to sell shares of its stock. Nevertheless, it's possible that the disposal caught some shareholders off guard.